Adamis Pharmaceuticals Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.96 |
Market Cap |
$60.98 M |
Shares Outstanding |
47.64 M |
Public Float |
40.4 M |
Address |
11682 El Camino Real San Diego California 92130 United States |
Employees | - |
Website | http://www.adamispharmaceuticals.com |
Updated | 07/08/2019 |
Adamis Pharmaceuticals Corp. is a biopharmaceutical company which is focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy. . Its activities include the combination of pharmaceuticals and biotechnology to produce medicines for patients, and physicians. |